ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Kane Biotech Inc

Kane Biotech Inc (KNE)

0.125
0.00
(0.00%)
Closed December 02 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.125
Bid
0.12
Ask
0.125
Volume
-
0.00 Day's Range 0.00
0.06 52 Week Range 0.17
Market Cap
Previous Close
0.125
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
97,704
Shares Outstanding
131,844,000
Dividend Yield
-
PE Ratio
-3.00
Earnings Per Share (EPS)
-0.04
Revenue
2.82M
Net Profit
-5.27M

About Kane Biotech Inc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Winnipeg, Manitoba, Can
Founded
-
Kane Biotech Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Exchange with ticker KNE. The last closing price for Kane Biotech was $0.13. Over the last year, Kane Biotech shares have traded in a share price range of $ 0.06 to $ 0.17.

Kane Biotech currently has 131,844,000 shares outstanding. The market capitalization of Kane Biotech is $16.48 million. Kane Biotech has a price to earnings ratio (PE ratio) of -3.00.

KNE Latest News

Kane Biotech Announces Third Quarter 2024 Financial Results

WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (โ€œKane Biotechโ€, โ€œKaneโ€ or the โ€œCompanyโ€) today announces its third quarter 2024 financial...

Kane Biotech Announces Change in US Distribution Partner for revyveโ„ขย Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the โ€œCompanyโ€, โ€œKane Biotechโ€ or โ€œKaneโ€) announces today that BioStem Technologies Inc...

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (โ€œKane Biotechโ€) will release its third quarter 2024 financial results after market close on...

Kane Biotech Announces Health Canada Approval of revyveโ„ขย Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the โ€œCompanyโ€ or โ€œKane Biotechโ€) announces today that it has received Health Canada approval of...

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the โ€œCompanyโ€, โ€œKane Biotechโ€) announces today that President & CEO, Marc Edwards and Dr...

L'Organisme canadien de rรฉglementation des investissements permet la reprise de la nรฉgociation - KNE

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - KNE Canada NewsWire VANCOUVER, BC, le 12 nov. 2024 VANCOUVER, BC, le 12 nov. 2024...

Canadian Investment Regulatory Organization Trade Resumption - KNE

Canadian Investment Regulatory Organization Trade Resumption - KNE Canada NewsWire VANCOUVER, BC, Nov. 12, 2024 VANCOUVER, BC, Nov. 12, 2024 /CNW/ - Trading resumes in: Company: Kane Biotech...

Kane Biotech Announces Agreement to Acquireย FB Dermatology

WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the โ€œCompanyโ€, โ€œKane Biotechโ€) announces today that it has entered into a binding term sheet...

Suspension de la nรฉgociation par l'Organisme canadien de rรฉglementation des investissements - KNE

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - KNE Canada NewsWire VANCOUVER, BC, le 12 nov. 2024 VANCOUVER, BC, le 12 nov. 2024 /CNW/...

Canadian Investment Regulatory Organization Trading Halt - KNE

Canadian Investment Regulatory Organization Trading Halt - KNE Canada NewsWire VANCOUVER, BC, Nov. 12, 2024 VANCOUVER, BC, Nov. 12, 2024 /CNW/ - The following issues have been halted by...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.01513.63636363640.110.130.111483900.12330919CS
4-0.005-3.846153846150.130.130.1912280.11676968CS
12-0.005-3.846153846150.130.1450.1977040.12427234CS
26-0.01-7.407407407410.1350.170.1998470.13686194CS
520.04556.250.080.170.061085050.12769118CS
156-0.035-21.8750.160.170.05674570.11639597CS
260-0.005-3.846153846150.130.260.05681210.13560996CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.035
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.43
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.035
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.43
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.035
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.43
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0

KNE Discussion

View Posts
teq0904 teq0904 11 months ago
They have been making about 2,500 samples per month in their lab for distribution to doctors for more than a month. By the time the contract plant starts up at the end of March there will be over 10k samples out so lots of doctors will be familiar with the product. You can bet they went to the burn centers and other of their top identified markets first.
๐Ÿ‘๏ธ0
teq0904 teq0904 1 year ago
Latest video on kne
https://www.facebook.com/KaneBiotechInc/videos/292568703569665
๐Ÿ‘๏ธ0
teq0904 teq0904 1 year ago
cc on Tuesday
๐Ÿ‘๏ธ0
teq0904 teq0904 1 year ago
Doesn't matter what you think the dog market is, because it will be sold. Strategic review nr.
๐Ÿ‘๏ธ0
teq0904 teq0904 1 year ago
First closing of the financing is probably next week. Officers and directors are in on it.
๐Ÿ‘๏ธ0
teq0904 teq0904 1 year ago
On the previous cc, Edwards said it is possible that the FDA will approve the manufacturing plant in time for the sales to start in Q4.
๐Ÿ‘๏ธ0
teq0904 teq0904 1 year ago
The next quarterly cc will be late in August.
๐Ÿ‘๏ธ0
teq0904 teq0904 1 year ago
The next step is for the outsourced manufacturing of coactiv+ to be completed. It may already be done, but it was supposed to take 3 months after receiving FDA approval.
๐Ÿ‘๏ธ0
teq0904 teq0904 1 year ago
They have FDA approval for coactiv+.
๐Ÿ‘๏ธ0
J_Dean J_Dean 4 years ago
This is the year. Letโ€™s go! :)
๐Ÿ‘๏ธ0
Golden Cross Golden Cross 5 years ago
Kane Biotech Announces Third Quarter 2019
Financial Results

https://backend.otcmarkets.com/otcapi/company/dns/news/document/40388/content
๐Ÿ‘๏ธ0
Golden Cross Golden Cross 5 years ago
KNBIF Website:

https://www.kanebiotech.com/
๐Ÿ‘๏ธ0
Golden Cross Golden Cross 5 years ago
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (56 patents and patents pending, trade secrets and trademarks) and products developed by the Companyโ€™s own biofilm research expertise and acquired from leading research institutions. StrixNBTM, DispersinB®, Aledex®, bluestemTM, AloSeraTM, coactiv+TM and Kane® are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE".
๐Ÿ‘๏ธ0
Golden Cross Golden Cross 5 years ago
Monster # of filings today $KNBIF

https://www.otcmarkets.com/stock/KNBIF/disclosure
๐Ÿ‘๏ธ0
sfld sfld 5 years ago
This might pump this week. Mentioned in a National Inflation Association newsletter today. GLTA
๐Ÿ‘๏ธ0
pegcitygreen pegcitygreen 6 years ago
I live in Winnipeg and have personally worked with this company. Great people, great products, but the company itself always seems to struggle. Kane products are for wealthy/well off people who love their pets and more than likely do not have any kids. A very, very niche market. Their tradeshows booth is quite impressive...but that doesn't mean impressive sales.
๐Ÿ‘๏ธ0
teq0904 teq0904 6 years ago
CEO got 2M shares in the market now.
๐Ÿ‘๏ธ0
teq0904 teq0904 6 years ago
Jan 30 cc and presentation shows the potential markets. Just sign into it and you end up with the archive. https://edge.media-server.com/m6/p/rzpqebyy
๐Ÿ‘๏ธ0
Macaveli Macaveli 6 years ago
Decent news released today. Plus insiders are buying. This is a hidden gem.
๐Ÿ‘๏ธ0
teq0904 teq0904 6 years ago
Sales are slow for this startup, however the products are superb so I imagine it will be a good company in the long run. I used the oral rinse and shampoo for my dog. I don't know if the rinse is the reason, but the vet told me this month that her teeth are in excellent shape for her age.
She also had a bad itch last winter and scratched day and night. It didn't stop with the use of a vet's prescription shampoo, so I tried the Kane product with excellent results. As soon as I put it on her she stops scratching for about 1 day, so I just apply it once daily wherever I see her scratching.

I know a guy who had terrible psoriasis itching on the scalp all day and night long but it all stopped when he used the human shampoo.
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock